Cargando…
Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al; PlaNeT-2 MATISSE Collaborators. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood. 2019;134(26):2354-2360.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555384/ https://www.ncbi.nlm.nih.gov/pubmed/32526023 http://dx.doi.org/10.1182/blood.2020006498 |
_version_ | 1784591967260246016 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8555384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-85553842021-11-02 Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al; PlaNeT-2 MATISSE Collaborators. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood. 2019;134(26):2354-2360. Blood Errata American Society of Hematology 2020-06-11 /pmc/articles/PMC8555384/ /pubmed/32526023 http://dx.doi.org/10.1182/blood.2020006498 Text en © 2020 by The American Society of Hematology This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Errata Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al; PlaNeT-2 MATISSE Collaborators. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood. 2019;134(26):2354-2360. |
title | Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al; PlaNeT-2 MATISSE Collaborators. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood. 2019;134(26):2354-2360. |
title_full | Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al; PlaNeT-2 MATISSE Collaborators. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood. 2019;134(26):2354-2360. |
title_fullStr | Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al; PlaNeT-2 MATISSE Collaborators. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood. 2019;134(26):2354-2360. |
title_full_unstemmed | Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al; PlaNeT-2 MATISSE Collaborators. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood. 2019;134(26):2354-2360. |
title_short | Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al; PlaNeT-2 MATISSE Collaborators. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood. 2019;134(26):2354-2360. |
title_sort | fustolo-gunnink sf, fijnvandraat k, van klaveren d, et al; planet-2 matisse collaborators. preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. blood. 2019;134(26):2354-2360. |
topic | Errata |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555384/ https://www.ncbi.nlm.nih.gov/pubmed/32526023 http://dx.doi.org/10.1182/blood.2020006498 |